Implantica announces live surgery with RefluxStop™ attended by nearly 2'000 surgeons and streamed by up to 100'000 online
07.08.2025 - 18:03:18 | prnewswire.co.ukAbout RefluxStop™
RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It's unique mechanism of action differentiates it from standard of care and current surgical solutions. Longer established surgical options for GERD involve encircling the food passageway to support the lower esophageal sphincter's closing mechanism and are commonly associated with side effects such as swallowing difficulties, pain when swallowing and inability to belch and/or vomit.
In contrast, the RefluxStop device treats the cause of acid reflux without encircling and putting pressure on the food passageway. It restores and maintains the lower esophageal sphincter in its original, natural position. The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.
Newsroom
https://www.implantica.com/media/media-kit
Media Contact:
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com
The following files are available for download:
https://mb.cision.com/Main/19732/3888068/2473862.pdf
Implantica announces live surgery with RefluxStop™ attended by nearly 2’000 surgeons and streamed by up to 100’000 online
https://news.cision.com/implantica/i/bonavina-live-surgery,c3245943
BONAVINA LIVE SURGERY
https://news.cision.com/implantica/i/logo-transparent-1-8,c3245944
logo transparent 1 8
https://news.cision.com/implantica/i/reluxstop-product,c3245945
ReluxStop Product
View original content:https://www.prnewswire.co.uk/news-releases/implantica-announces-live-surgery-with-refluxstop-attended-by-nearly-2000-surgeons-and-streamed-by-up-to-100000-online-302005590.html
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Für. Immer. Kostenlos

